|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abdeen Y, Amireh S, Patel A, Al-Halawani
M, Shaaban H and Miller R: Cutaneous metastasis as a first
presentation for lung adenocarcinoma. N Am J Med Sci. 8:222–225.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dao A, Jabir H, Taleb A, Benchakroun N,
Bouchbika Z, Nezha T, Jouhadi H, Sahraoui S and Benider A: Lung
adenocarcinoma with thyroid metastasis: A case report. BMC Res
Notes. 10:1302017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li H, Lian J, Han S, Wang W, Jia H, Cao J,
Zhang X, Song X, Jia S, Ren J, et al: Applicability of graded
prognostic assessment of lung cancer using molecular markers to
lung adenocarcinoma patients with brain metastases. Oncotarget.
8:70727–70735. 2017.PubMed/NCBI
|
|
5
|
Yu M, Su Y, Cui D, Sun Q, Luan B and Zhao
D: Chemotherapy effectively suppresses interleukin-20, receptor
activator of nuclear factor kappa-B ligand, and osteoprotegerin
levels in patients with lung adenocarcinoma and bone metastasis. J
Cancer Res Ther. 12:963–968. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Behera M, Owonikoko TK, Gal AA, Steuer CE,
Kim S, Pillai RN, Khuri FR, Ramalingam SS and Sica GL: Lung
adenocarcinoma staging using the 2011 IASLC/ATS/ERS classification:
A pooled analysis of adenocarcinoma in situ and minimally invasive
adenocarcinoma. Clin Lung Cancer. 17:e57–e64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Borczuk AC: Prognostic considerations of
the new World Health Organization classification of lung
adenocarcinoma. Eur Respir Rev. 25:364–371. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen B, Ma J, Li C and Wang Y: Long
noncoding RNA KCNQ1OT1 promotes proliferation and
epithelial-mesenchymal transition by regulation of SMAD4 expression
in lens epithelial cells. Mol Med Rep. 18:16–24. 2018.PubMed/NCBI
|
|
9
|
Wang L, Ma L, Xu F, Zhai W, Dong S, Yin L,
Liu J and Yu Z: Role of long non-coding RNA in drug resistance in
non-small cell lung cancer. Thorac Cancer. 9:761–768. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Lu Z, Wang N, Feng J, Zhang J,
Luan L, Zhao W and Zeng X: Long noncoding RNA DANCR promotes
colorectal cancer proliferation and metastasis via miR-577
sponging. Exp Mol Med. 50:572018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Zhang Y, Yang T, Zhao W, Wang N,
Li P, Zeng X and Zhang W: Long non-coding RNA MALAT1 for promoting
metastasis and proliferation by acting as a ceRNA of miR-144-3p in
osteosarcoma cells. Oncotarget. 8:59417–59434. 2017.PubMed/NCBI
|
|
12
|
Wu X, Zheng Y, Han B and Dong X: Long
noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin
resistance of gastric cancer via sponging miR-361. Biomed
Pharmacother. 99:832–838. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu
J, Miao N, Shen J and Peng T: lncRNA DANCR promotes tumor
progression and cancer stemness features in osteosarcoma by
upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 405:46–55.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma X, Wang X, Yang C, Wang Z, Han B, Wu L
and Zhuang L: DANCR Acts as a diagnostic biomarker and promotes
tumor growth and metastasis in hepatocellular carcinoma. Anticancer
Res. 36:6389–6398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan L, Liang W, Gu J, Zang X, Huang Z, Shi
H, Chen J, Fu M, Zhang P, Xiao X, et al: Long noncoding RNA DANCR
is activated by SALL4 and promotes the proliferation and invasion
of gastric cancer cells. Oncotarget. 9:1915–1930. 2017.PubMed/NCBI
|
|
16
|
Sha S, Yuan D, Liu Y, Han B and Zhong N:
Targeting long non-coding RNA DANCR inhibits triple negative breast
cancer progression. Biol Open. 6:1310–1316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu QC, Rui ZH, Guo ZL, Xie W, Shan S and
Ren T: lncRNA-DANCR contributes to lung adenocarcinoma progression
by sponging miR-496 to modulate mTOR expression. J Cell Mol Med.
22:1527–1537. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johnson KR, Lehn DA and Reeves R:
Alternative processing of mRNAs encoding mammalian chromosomal
high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol.
9:2114–2123. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pallante P, Sepe R, Puca F and Fusco A:
High mobility group a proteins as tumor markers. Front Med
(Lausanne). 2:152015.PubMed/NCBI
|
|
20
|
Chang HY, Ye SP, Pan SL, Kuo TT, Liu BC,
Chen YL and Huang TC: Overexpression of miR-194 Reverses
HMGA2-driven Signatures in Colorectal Cancer. Theranostics.
7:3889–3900. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang C, Cao Y, Lei T, Wang Y, Fu J, Wang
Z and Lv Z: microRNA-363-3p inhibits cell growth and invasion of
non-small cell lung cancer by targeting HMGA2. Mol Med Rep.
17:2712–2718. 2018.PubMed/NCBI
|
|
22
|
Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J and
Shi ZZ: miR-125b-5p functions as a tumor suppressor gene partially
by regulating HMGA2 in esophageal squamous cell carcinoma. PLoS
One. 12:e01856362017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Šamija I, Mateša N, Kožaj S, Majstorović
I, Bolanča A and Kusić Z: HMGA2 gene expression in fine-needle
aspiration samples of thyroid nodules as a marker for preoperative
diagnosis of thyroid cancer. Appl Immunohistochem Mol Morphol. Feb
5–2018.(Epub ahead of print). doi: 10.1097/PAI.0000000000000637.
View Article : Google Scholar :
|
|
24
|
Zhu J, Wang H, Xu S and Hao Y:
Clinicopathological and prognostic significance of HMGA2
overexpression in gastric cancer: A meta-analysis. Oncotarget.
8:100478–100489. 2017.PubMed/NCBI
|
|
25
|
Zhuo HC, Song YF, Ye J, Lai GX and Liu DL:
MicroRNA-154 functions as a tumor suppressor and directly targets
HMGA2 in human non-small cell lung cancer. Genet Mol Res. 15:2016.
View Article : Google Scholar :
|
|
26
|
Meyer B, Loeschke S, Schultze A, Weigel T,
Sandkamp M, Goldmann T, Vollmer E and Bullerdiek J: HMGA2
overexpression in non-small cell lung cancer. Mol Carcinog.
46:503–511. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu L, Liao WL, Lu QJ, Li CG, Yuan Y, Xu
ZY, Huang SD and Chen HZ: ANG promotes proliferation and invasion
of the cell of lung squamous carcinoma by directly up-regulating
HMGA2. J Cancer. 7:862–871. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Wang S, Li Z, Long X, Guo Z, Zhang
G, Zu J, Chen Y and Wen L: The lncRNA NEAT1 facilitates cell growth
and invasion via the miR-211/HMGA2 axis in breast cancer. Int J
Biol Macromol. 105:346–353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Sun J, Wei X, Luan L, Zeng X, Wang
C and Zhao W: Decrease of miR-622 expression suppresses migration
and invasion by targeting regulation of DYRK2 in colorectal cancer
cells. OncoTargets Ther. 10:1091–1100. 2017. View Article : Google Scholar
|
|
31
|
Wang Y, Yang T, Liu Y, Zhao W, Zhang Z, Lu
M and Zhang W: Decrease of miR-195 promotes chondrocytes
proliferation and maintenance of chondrogenic phenotype via
targeting FGF-18 pathway. Int J Mol Sci. 18(pii): E9752017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kretz M, Webster DE, Flockhart RJ, Lee CS,
Zehnder A, Lopez-Pajares V, Qu K, Zheng GX, Chow J, Kim GE, et al:
Suppression of progenitor differentiation requires the long
noncoding RNA ANCR. Genes Dev. 26:338–343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Zheng J, Xue Y, Yu H, Gong W, Wang
P, Li Z and Liu Y: PIWIL3/OIP5-AS1/miR-367-3p/CEBPA feedback loop
regulates the biological behavior of glioma cells. Theranostics.
8:1084–1105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Su R, Cao S, Ma J, Liu Y, Liu X, Zheng J,
Chen J, Liu L, Cai H, Li Z, et al: Knockdown of SOX2OT inhibits the
malignant biological behaviors of glioblastoma stem cells via
up-regulating the expression of miR-194-5p and miR-122. Mol Cancer.
16:1712017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu J, Ding R and Xu Y: Effects of long
non-coding RNA SPRY4-IT1 on osteosarcoma cell biological behavior.
Am J Transl Res. 8:5330–5337. 2016.PubMed/NCBI
|
|
36
|
Zhang L, Yang C, Chen S, Wang G, Shi B,
Tao X, Zhou L and Zhao J: Long noncoding RNA DANCR is a positive
regulator of proliferation and chondrogenic differentiation in
human synovium-derived stem cells. DNA Cell Biol. 36:136–142. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang S and Jiang M: The long non-coding
RNA-DANCR exerts oncogenic functions in non-small cell lung cancer
via miR-758-3p. Biomed Pharmacother. 103:94–100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhen Q, Gao LN, Wang RF, Chu WW, Zhang YX,
Zhao XJ, Lv BL and Liu JB: lncRNA DANCR promotes lung cancer by
sequestering miR-216a. Cancer Control. 25:10732748187698492018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cleynen I and Van de Ven WJ: The HMGA
proteins: A myriad of functions (Review). Int J Oncol. 32:289–305.
2008.PubMed/NCBI
|
|
40
|
Sun J, Sun B, Zhu D, Zhao X, Zhang Y, Dong
X, Che N, Li J, Liu F, Zhao N, et al: HMGA2 regulates CD44
expression to promote gastric cancer cell motility and sphere
formation. Am J Cancer Res. 7:260–274. 2017.PubMed/NCBI
|
|
41
|
Fan C, Lin Y, Mao Y, Huang Z, Liu AY, Ma
H, Yu D, Maitikabili A, Xiao H, Zhang C, et al: MicroRNA-543
suppresses colorectal cancer growth and metastasis by targeting
KRAS, MTA1 and HMGA2. Oncotarget. 7:21825–21839. 2016.PubMed/NCBI
|
|
42
|
Yang E, Cisowski J, Nguyen N, O'Callaghan
K, Xu J, Agarwal A, Kuliopulos A and Covic L: Dysregulated protease
activated receptor 1 (PAR1) promotes metastatic phenotype in breast
cancer through HMGA2. Oncogene. 35:1529–1540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gao X, Dai M, Li Q, Wang Z, Lu Y and Song
Z: HMGA2 regulates lung cancer proliferation and metastasis. Thorac
Cancer. 8:501–510. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Akhade VS, Pal D and Kanduri C: Long
noncoding RNA: Genome organization and mechanism of action. Adv Exp
Med Biol. 1008:47–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
